Optigenex Inc (OPGX) 0.0500 $OPGX
Optigenex Inc. Cautions Consumers to Be Aware of a Product Called "FUSION Powered by ac-11(R)", a Weight Loss Formula that Does Not Comply with Published Data on ac-11(R) Efficacy and Is Not Authorized by Optigenex, the Owner of ac-11(R)
ACCESSWIRE - Mon Dec 22, 11:45AM CST
Optigenex Reports that the Company is Taking Legal Measures Stop Further Manufacturing of FUSION, Along With Several Other Unauthorized ac-11(R) Products
Optigenex Inc. Reports New Research Milestone for Onnit Labs Proprietary Supplement, Alpha BRAIN(TM) with ac-11(R)
eTeligis - Wed Dec 17, 7:21AM CST
HOBOKEN, NJ, United States, via ETELIGIS INC., 12/17/2014 - - Optigenex Inc. (OTC Pink: OPGX) (PINKSHEETS: OPGX), announced today results of an Onnit Labs sponsored clinical trial validating the effectiveness of Onnit's highly popular, nutrient-based supplement called Alpha BRAIN with ac-11(R) in enhancing verbal memory, mental focus and other vital cognitive functions. The work, which was conducted by the world-famous Boston Memory Center, involved 63 volunteer patients participating in a randomized, double blind, placebo controlled clinical trial using AlphaBRAIN orally administered. As reported by the Center, the clinical trial fully confirmed the results of an earlier "proof of concept" pilot study that was conducted by the Center earlier this year.
Optigenex and Hill Pharma Enter Into Agreement to Develop Innovative Sports Nutrition and Weight Management Products
ACCESSWIRE - Tue Oct 07, 8:15AM CDT
Companies Plan to Unveil Initial Product Offerings at Supply Side West in Las Vegas, Nevada on October 8, 2014
Optigenex Inc. Cautions Consumers to Be Aware of a Product Called "FUSION Powered by ac-11(R)", a Weight Loss Formula that Does Not Comply with Published Data on ac-11(R) Efficacy and Is Not Authorized by Optigenex, the Owner of ac-11(R)
ACCESSWIRE - Mon Dec 22, 11:45AM CST
Optigenex Reports that the Company is Taking Legal Measures Stop Further Manufacturing of FUSION, Along With Several Other Unauthorized ac-11(R) Products
Optigenex Inc. Reports New Research Milestone for Onnit Labs Proprietary Supplement, Alpha BRAIN(TM) with ac-11(R)
eTeligis - Wed Dec 17, 7:21AM CST
HOBOKEN, NJ, United States, via ETELIGIS INC., 12/17/2014 - - Optigenex Inc. (OTC Pink: OPGX) (PINKSHEETS: OPGX), announced today results of an Onnit Labs sponsored clinical trial validating the effectiveness of Onnit's highly popular, nutrient-based supplement called Alpha BRAIN with ac-11(R) in enhancing verbal memory, mental focus and other vital cognitive functions. The work, which was conducted by the world-famous Boston Memory Center, involved 63 volunteer patients participating in a randomized, double blind, placebo controlled clinical trial using AlphaBRAIN orally administered. As reported by the Center, the clinical trial fully confirmed the results of an earlier "proof of concept" pilot study that was conducted by the Center earlier this year.
Optigenex and Hill Pharma Enter Into Agreement to Develop Innovative Sports Nutrition and Weight Management Products
ACCESSWIRE - Tue Oct 07, 8:15AM CDT
Companies Plan to Unveil Initial Product Offerings at Supply Side West in Las Vegas, Nevada on October 8, 2014
